NeuroQore Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| NQ Square TMS for MDD 1Dx3S Adults Multi-site Sham-controlled Protocol (NCT07369180) | NeuroQore Inc. | 2026-01-15 |
| NQ TMS for MDD Therapy Using 1 Day x 3 Sessions Protocol for Adult Patient (NCT06772987) | NeuroQore Inc. | 2025-01-16 |
| Linear Asymmetric rTMS in Adolescent Treatment-Resistant Depression: Tolerability of Treatment Durations Ranging From Ten Days to One Day (NCT03986658) | NeuroQore Inc. | 2022-03-01 |
Track NeuroQore Inc. automatically
Every clearance here is in the API, with alerts when new ones post.